Sotera Health (NASDAQ:SHC) Holdings Raised by Voss Capital LP

Voss Capital LP increased its position in shares of Sotera Health (NASDAQ:SHC - Free Report) by 42.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 500,000 shares of the company's stock after acquiring an additional 150,000 shares during the quarter. Voss Capital LP owned approximately 0.18% of Sotera Health worth $6,840,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in SHC. Blue Trust Inc. raised its holdings in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after buying an additional 1,140 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after acquiring an additional 1,121 shares in the last quarter. Sterling Capital Management LLC boosted its position in Sotera Health by 58.5% during the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock worth $124,000 after purchasing an additional 3,331 shares during the period. PNC Financial Services Group Inc. increased its holdings in Sotera Health by 39.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock valued at $127,000 after purchasing an additional 2,627 shares in the last quarter. Finally, Optimize Financial Inc purchased a new position in Sotera Health in the fourth quarter valued at about $185,000. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Stock Down 1.3 %

NASDAQ SHC traded down $0.15 during mid-day trading on Friday, reaching $11.15. 960,744 shares of the company's stock traded hands, compared to its average volume of 1,204,178. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a 1-year low of $9.53 and a 1-year high of $17.08. The company has a fifty day simple moving average of $11.56 and a 200-day simple moving average of $13.17. The company has a market cap of $3.16 billion, a price-to-earnings ratio of 44.60 and a beta of 1.88.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on SHC shares. Piper Sandler lowered their target price on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday. Barclays lowered their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $15.20.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.